| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $13.06K | $13.00K | $13.50K | $23.60K | $252.49K |
| Operating Income | -$192.61K | -$224.65K | -$219.63K | -$277.90K | -$312.97K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | $0.00 | $0.00 | – |
| Net Income | -$185.66K | -$204.65K | $66.59K | -$257.91K | $21.19K |
| EPS (basic) | 0.0000 | -0.0100 | 0.0000 | -0.0100 | 0.0000 |
| EPS (diluted) | 0.0000 | -0.0100 | 0.0000 | -0.0100 | 0.0000 |
| Shares (diluted) | $38.91M | $38.91M | $38.91M | $38.91M | $39.95M |